Details of the Drug Reposition

General Information of This Drug (ID: DMD09CT)

Drug Name
LY-362884   DMD09CT
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Type-2 diabetes DIS3X247 5A11 Phase 2 [1]
Obesity DIS47Y1K 5B81 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60.